Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias

Inclusion Criteria: * Patient receiving hemodialysis at a DaVita clinic/dialysis center * Receiving in-center hemodialysis thrice weekly * Central venous catheter (CVC) use for \> 180 days * Patients report a fear of needles as a top-3-reason for failure to get an arteriovenous fistula/graft Exclusion Criteria: * Patients have a known intolerance or hypersensitivity to Synera * Patient with a history of or past diagnosis of severe hepatic disease * Patient is currently receiving any class 1 antiarrhythmic drugs (i.e., tocainide, mexiletine, etc) * Patient has a clinically significant illness within 14 days of Screening/Day 1 that, in the opinion of the investigator, would preclude the subject from participating in the study * Patient has an AVF or AVG in place or is scheduled for placement * Women and men whose partners are of childbearing potential (defined as premenopausal and not surgically sterilized \[ie, bilateral tubal ligation, bilateral oophorectomy, or hysterectomy\] or postmenopausal for \< 2 years) agree to practice 1 of the following medically acceptable methods of birth control and agree to continue with the regimen throughout the duration of the study: Oral, implantable, or injectable contraceptives for 3 consecutive months before the Screening Visit; Intrauterine device (IUD); and double barrier method (ie, condom, sponge, diaphragm, or vaginal ring with spermicidal jellies or cream) * Patient has significant disease or condition that, in the PI's opinion, …